Kristine D. Harper

Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women

Elizabeth Barrett‐Connor, Deborah Grady, Andreas Sashegyi et al. · JAMA · 2002 · 574 citations

Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial

Pierre D. Delmas, Kristine E. Ensrud, Jonathan D. Adachi et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 537 citations · Full text

Randomized Clinical Trial, Pharmacotherapy, Surgery +17

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Somnath Sarkar, Bruce Mitlak, Mayme Wong et al. · Journal of Bone and Mineral Research · 2002 · 449 citations · Full text

A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women

Michael W. Draper, David E. Flowers, William J. Huster et al. · Journal of Bone and Mineral Research · 1996 · 355 citations

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: Results from the Multiple Outcomes of Raloxifene Evaluation Study

Stuart L. Silverman, Michael E. Minshall, Wei Shen et al. · Arthritis & Rheumatism · 2001 · 343 citations